Hsp27 reduces glycation‐induced toxicity and aggregation of alpha‐synuclein
Open Access
- 7 April 2020
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 34 (5) , 6718-6728
Abstract
α‐synuclein (aSyn) is a major player in Parkinson's disease and a group of other disorders collectively known as synucleinopathies, but the precise molecular mechanisms involved are still unclear. aSyn, as virtually all proteins, undergoes a series of posttranslational modifications during its lifetime, which can affect its biology and pathobiology. We recently showed that glycation of aSyn by methylglyoxal (MGO) potentiates its oligomerization and toxicity, induces dopaminergic neuronal cell loss in mice, and affects motor performance in flies. Small heat‐shock proteins (sHsps) are molecular chaperones that facilitate the folding of proteins or target misfolded proteins for clearance. Importantly, sHsps were shown to prevent aSyn aggregation and cytotoxicity. Upon treating cells with increasing amounts of methylglyoxal, we found that the levels of Hsp27 decreased in a dose‐dependent manner. Therefore, we hypothesized that restoring the levels of Hsp27 in glycating environments could alleviate the pathogenicity of aSyn. Consistently, we found that Hsp27 reduced MGO‐induced aSyn aggregation in cells, leading to the formation of nontoxic aSyn species. Remarkably, increasing the levels of Hsp27 suppressed the deleterious effects induced by MGO. Our findings suggest that in glycating environments, the levels of Hsp27 are important for modulating the glycation‐associated cellular pathologies in synucleinopathies.Keywords
All Related Versions
Funding Information
- Fundação para a Ciência e Tecnologia (PTDC/NEU-OSD/5644/2014, EXPL/NEU-OSD/0606/2012, SFRH/BPD/109347/2015, EXPL/NEU-OSD/0606/2012, PD/BD/136863/2018, PTDC/NEU-OSD/5644/2014)
- EU Joint Programme - Neurodegenerative Disease Research
This publication has 79 references indexed in Scilit:
- Assessing the Subcellular Dynamics of Alpha-synuclein Using Photoactivation MicroscopyMolecular Neurobiology, 2013
- α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered MonomerJournal of Biological Chemistry, 2012
- Pathological roles of α-synuclein in neurological disordersThe Lancet Neurology, 2011
- Molecular chaperones in protein folding and proteostasisNature, 2011
- Phosphorylation Dynamics Regulate Hsp27-Mediated Rescue of Neuronal Plasticity Deficits in Tau Transgenic MiceJournal of Neuroscience, 2010
- The pivotal role of the β7 strand in the intersubunit contacts of different human small heat shock proteinsCell Stress and Chaperones, 2010
- Small heat shock proteins protect against α-synuclein-induced toxicity and aggregationBiochemical and Biophysical Research Communications, 2006
- Wrapping the α-Crystallin Domain Fold in a Chaperone AssemblyJournal of Molecular Biology, 2005
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998
- NACP, A Protein Implicated in Alzheimer's Disease and Learning, Is Natively UnfoldedBiochemistry, 1996